eStoreRx™
Online Supplement Dispensary
eStoreRx™ is an easy direct-to-patient ordering & fulfilment program for lifelong wellness.
For over 40 years, Biotics Research Corporation has revolutionized the nutritional supplement industry by utilizing “The Best of Science and Nature”. Combining nature’s principles with scientific ingenuity, our products magnify the nutritional
eStoreRx™ is an easy direct-to-patient ordering & fulfilment program for lifelong wellness.
Biotics Research is proud to expand our commitment to education with the Wellness Unfiltered Pro Podcast. Each episode delves into key health topics and the clinical applications of our premier products. Through candid, insightful conversations, our team offers practical guidance to keep you informed and empowered as a healthcare professional.
December 20 2024
The British Journal of Sports Medicine recently published a systematic review that analyzed the effects of postpartum exercise on maternal postpartum ...
Recent evidence suggests the long term use of chondroitin and glucosamine supplements may be linked to reduced risk of colorectal cancer (CRC). Researchers evaluated the association between the use of these compounds and the risk of CRC in two prospective cohorts; the Nurses’ Health Study and the Health Professionals Follow-up Study. Regular use of these supplements was first assessed in 2002 and were followed until 2010. 672 CRC cases occurred over that time. Cox proportional hazards regression was used to estimate relative risks (RRs) within each cohort, and results were pooled using a random effects meta analysis. Associations were comparable across cohorts, with a RR of 0.79 observed for any use of glucosamine and a RR of 0.77 observed for any use of chondroitin. Use of glucosamine in the absence of chondroitin was not associated with risk of CRC, whereas use of chondroitin and glucosamine was significantly associated with risk. The association was comparable for cancers of the colon and rectum. Results support a protective association between the use of chondroitin and glucosamine and risk of CRC.
Fuchs C, Giovannucci E; Use of glucosamine and chondroitin supplements in relation to risk of colorectal cancer: Results from the Nurses’ Health Study and Health Professionals Follow-up Study. International Journal of Cancer (June 2016).
Submit this form and you'll receive our latest news and updates.
*These statements have not been evaluated by the Food and Drug Administration. This product has not intended to diagnose, treat, cure, or prevent any disease.
© 2023 Biotics Research Corporation - All Rights Reserved
Submit your comment